“It is unlikely that most patients could start treatment much before 4 weeks, given the need to recover from surgery and complete the pathologic assessment, which increasingly includes complex biomarkerbased studies,” adds Dr. Yu. “There is no suggestion that it is deleterious to start sooner rather than later if the patient’s condition allows, so all things being equal, we should strive to start sooner in my opinion.” Dr. Yu also points out that a related operational challenge is how to optimize workflow to permit the earlier initiation of chemotherapy. Improved communication and coordination between multidisciplinary specialists and patient education are essential, he says.

中文翻译：

---

结构化姑息治疗计划被发现有助于肺癌患者的护理人员

“鉴于需要从手术中恢复并完成病理评估，其中越来越多地包括基于复杂生物标志物的研究，大多数患者不太可能在 4 周之前开始治疗，”于博士补充道。“没有任何迹象表明，如果患者的病情允许，早晚开始是有害的，所以在所有条件相同的情况下，我认为我们应该争取早点开始。” Yu 博士还指出，一个相关的操作挑战是如何优化工作流程以允许更早开始化疗。他说，改善多学科专家和患者教育之间的沟通和协调至关重要。